Alternate-Day Buprenorphine Dosing for Improved Treatment Compliance

This study focuses on exploring the long-term effectiveness of alternate-day dosing schedules for buprenorphine, a medication used to treat opioid dependence. The goal is to understand if this dosing schedule can improve treatment compliance when there are no other influencing factors. The study is designed for individuals struggling with opioid dependence, aiming to provide a treatment approach that could potentially make their recovery journey more manageable. Participants in this study will receive buprenorphine following an alternate-day dosing schedule. The study measures several outcomes to evaluate the treatment's success. These include assessing drug use, opioid dependence and psychiatric status, overall treatment outcome, retention in the treatment program, and the number of weeks participants remain abstinent from opioids. The study also looks at the number of weeks participants maintain continuous abstinence.